Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome - Rohner, M; Heiz, R; Feldhaus, S; Bornstein, SR (Horm Metab Res, 2021)